Description

4-[3-[[3-(2,3-Dihydro-2-Oxo-1H-Benzimidazol-1-Yl)Propyl](Phenylmethyl)Amino]-2-Hydroxypropoxy]Phenylacetamide is a high-purity, complex organic compound with a benzimidazolone core, serving as a critical advanced intermediate in pharmaceutical synthesis. Its molecular structure is engineered to act as a key building block for the development of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted receptor modulation. This compound is essential for research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates, where precise chemical structure and high purity are non-negotiable for successful outcomes.

Application

• Pharmaceutical Intermediate: Primary use as a sophisticated building block in the multi-step synthesis of novel drug candidates.
• API (Active Pharmaceutical Ingredient) Development: Serves as a core structural component in the research and scale-up of new therapeutic agents.
• Biochemical Research: Used in life science research for studying enzyme interactions, receptor binding assays, and pharmacological profiling.
• Preclinical & Clinical Trial Material: Supplied under controlled conditions for the production of materials used in non-clinical and clinical studies.
• Contract Manufacturing (CMO): A key material for Contract Manufacturing Organizations specializing in complex organic synthesis for the pharma industry.

Basic Information

Product Name	4-[3-[[3-(2,3-Dihydro-2-Oxo-1H-Benzimidazol-1-Yl)Propyl](Phenylmethyl)Amino]-2-Hydroxypropoxy]Phenylacetamide
CAS No.	84255-04-9
Molecular Formula	C28H30N4O4
Molecular Weight	486.56 g/mol
Synonyms	N-[4-[3-[[3-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)propyl](phenylmethyl)amino]-2-hydroxypropoxy]phenyl]acetamide; 4-[3-[[3-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl](benzyl)amino]-2-hydroxypropoxy]phenylacetamide; UNII-6W6P7SX85R; 6W6P7SX85R; Benzamil intermediate; 84255-04-9
EINECS	Contact for details

Quality Control

Our 4-[3-[[3-(2,3-Dihydro-2-Oxo-1H-Benzimidazol-1-Yl)Propyl](Phenylmethyl)Amino]-2-Hydroxypropoxy]Phenylacetamide is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research and pharmaceutical applications. All products undergo rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to verify identity and purity. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with each shipment to support your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The compound is light-sensitive (store away from light). Keep the container tightly sealed in a dry environment to prevent moisture absorption. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.